(Q39727960)

English

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience

scientific article published on 18 July 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

10

object named as

M A Dimopoulos

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

A Bamias

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A Karadimou

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

N Soupos

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

M Sotiropoulou

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

F Zagouri

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

D Haidopoulos

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

N Thomakos

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A Rodolakis

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A Antsaklis

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

18 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

37-42

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Natural history and prognosis of untreated stage I epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Prognostic factors for stage I ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Histopathologic grading of ovarian carcinoma: a review and proposal

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Improved Overall Survival with 12 Cycles of Single-Agent Paclitaxel Maintenance Therapy following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.06.033

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.06.033

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39727960&oldid=2089172701"